Literature DB >> 25719259

Natural Killer Cells Mediate Long-term Kidney Allograft Injury.

Zhu-Xu Zhang1, Xuyan Huang, Jifu Jiang, Arthur Lau, Ziqin Yin, Weihua Liu, Aaron Haig, Anthony M Jevnikar.   

Abstract

BACKGROUND: Chronic allograft injury remains the leading cause of late kidney graft loss despite improvements in immunosuppressive drugs and a reduction in acute T cell-mediated rejection. We have recently demonstrated that natural killer (NK) cells are cytotoxic to tubular epithelial cells and contribute to acute kidney ischemia-reperfusion injury. The role of NK cells in kidney allograft rejection has not been studied.
METHODS: A "parent to F1" kidney transplant model was used to study NK cell-mediated transplant rejection.
RESULTS: The C57BL/6 kidneys were transplanted into fully nephrectomized CB6F1 (C57BL/6 x BALB/c) mice. Serum creatinine levels increased from baseline (18.8 ± 5.0 μmol/L to 37.2 ± 5.9 μmol/L, P < 0.001) at 60 days after transplantation. B6Rag-to-CB6F1Rag (B6RagxBALB/cRag) recipients, which lack T and B cells but retain NK cells, showed similar levels of kidney dysfunction 65 days after transplantation (creatinine, 33.8 ± 7.9 μmol/L vs 17.5 ± 5.1 μmol/L in nontransplant Rag mice, P < 0.05). Importantly, depletion of NK cells in Rag1 recipients inhibited kidney injury (24.6 ± 5.5 μmol/L, P < 0.05). Osteopontin, which can activate NK cells to mediate tubular epithelial cell death in vitro, was highly expressed in 60 days kidney grafts. Osteopontin null kidney grafts had reduced injury after transplantation into CB6F1 mice (17.7 ± 3.1 μmol/L, P < 0.001).
CONCLUSIONS: Collectively, these data demonstrate for the first time that independent of T and B cells, NK cells have a critical role in mediating long-term transplant kidney injury. Specific therapeutic strategies that target NK cells in addition to conventional immunosuppression may be required to attenuate chronic kidney transplant injury.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25719259     DOI: 10.1097/TP.0000000000000665

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  19 in total

1.  Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies.

Authors:  Jasper Callemeyn; Evelyne Lerut; Henriette de Loor; Ingrid Arijs; Olivier Thaunat; Alice Koenig; Vannary Meas-Yedid; Jean-Christophe Olivo-Marin; Philip Halloran; Jessica Chang; Lieven Thorrez; Dirk Kuypers; Ben Sprangers; Leentje Van Lommel; Frans Schuit; Marie Essig; Wilfried Gwinner; Dany Anglicheau; Pierre Marquet; Maarten Naesens
Journal:  J Am Soc Nephrol       Date:  2020-07-08       Impact factor: 10.121

2.  Fingering a Natural Culprit During Antibody-Mediated Rejection.

Authors:  Robert L Fairchild
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 3.  T Cells Going Innate.

Authors:  Midas Seyda; Abdallah Elkhal; Markus Quante; Christine S Falk; Stefan G Tullius
Journal:  Trends Immunol       Date:  2016-07-08       Impact factor: 16.687

4.  IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: compensatory role of natural killer cells in athymic rats.

Authors:  Purvi Mehrotra; Jason A Collett; Seth D McKinney; Jackson Stevens; Carlie M Ivancic; David P Basile
Journal:  Am J Physiol Renal Physiol       Date:  2016-11-16

Review 5.  Recall features and allorecognition in innate immunity.

Authors:  Hirofumi Uehara; Koichiro Minami; Markus Quante; Yeqi Nian; Timm Heinbokel; Haruhito Azuma; Abdala El Khal; Stefan G Tullius
Journal:  Transpl Int       Date:  2017-10-20       Impact factor: 3.782

6.  Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant Rejection.

Authors:  Michael D Parkes; Philip F Halloran; Luis G Hidalgo
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 7.  Indoleamine 2,3 Dioxygenase 1-The Potential Link between the Innate Immunity and the Ischemia-Reperfusion-Induced Acute Kidney Injury?

Authors:  Anna Krupa; Mikolaj M Krupa; Krystyna Pawlak
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

8.  Osteopontin Blockade Attenuates Renal Injury After Ischemia Reperfusion by Inhibiting NK Cell Infiltration.

Authors:  Cindy Cen; Monowar Aziz; Weng-Lang Yang; Jeffrey M Nicastro; Gene F Coppa; Ping Wang
Journal:  Shock       Date:  2017-01       Impact factor: 3.454

9.  NK Cells of Kidney Transplant Recipients Display an Activated Phenotype that Is Influenced by Immunosuppression and Pathological Staging.

Authors:  Ulrike Hoffmann; Christine Neudörfl; Kerstin Daemen; Jana Keil; Maja Stevanovic-Meyer; Frank Lehner; Hermann Haller; Cornelia Blume; Christine S Falk
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

10.  Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies.

Authors:  Tristan Legris; Christophe Picard; Dilyana Todorova; Luc Lyonnet; Cathy Laporte; Chloé Dumoulin; Corinne Nicolino-Brunet; Laurent Daniel; Anderson Loundou; Sophie Morange; Stanislas Bataille; Henri Vacher-Coponat; Valérie Moal; Yvon Berland; Francoise Dignat-George; Stéphane Burtey; Pascale Paul
Journal:  Front Immunol       Date:  2016-08-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.